MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2024 International Congress

    Cognitive profile of Parkinson’s disease (PD) in the Framingham Heart Study (FHS)

    A. Gurnani, J. Dookhy, Y. Liu, Y. Li, S. O'Shea, S. Frank, R. Au, J. Mez, T. Alvin Ang, L. Shih (Framingham, USA)

    Objective: Characterize the cognitive profiles of individuals with PD within a population-based study Background: Understanding the cognitive state of those with PD early in its…
  • 2024 International Congress

    Outcomes in Patients with Parkinsonism Treated for Acute Agitation with Intravenous Benzodiazepines Compared to Parenteral Antipsychotics While Inpatient

    A. Kundrick, C. Piccinin, J. Yu, P. Clark, S. Shaffer, O. Hogue, C. Sonneborn, B. Sokola, S. Sperling, H. Fernandez, B. Walter (Cleveland, USA)

    Objective: To determine whether patients with parkinsonism and severe agitation while inpatient have better outcomes when treated with parenteral benzodiazepines instead of parenteral antipsychotics. Background:…
  • 2024 International Congress

    Relationships of blood Vitamin B12 and Homocysteine with Parkinson’s Disease Progression in 3 Contemporary Clinical Trials

    C. Christine, P. Auinger, E. Forti, L. Tat, N. Cannizzaro, D. Oakes, R. Green (San Francisco, USA)

    Objective: To measure blood levels of vitamin B12 and homocysteine (tHcy) in contemporary clinical trial participants and to determine whether these analytes were associated with…
  • 2024 International Congress

    Performance of a Smartphone-based Oculomotor Test as a Diagnostic Tool for Parkinson’s Disease

    C. Edwards, A. Zirra, IA. John, A. Bogucki, R. Torricelli, J. Kenny, S. Ganesh, K. Dey, T. Haque, D. Gallagher, C. Budu, C. Simonet, M. Wlodarski, J. Neffendorf, R. Chrapkiewicz, SG. Manohar, AJ. Noyce (London, United Kingdom)

    Objective: First, to ascertain whether a smartphone-based application measuring saccadic parameters can differentiate between patients with Parkinson’s disease (PD) and healthy controls (HC). Second, to…
  • 2024 International Congress

    Vestibulo-ocular reflex and cognitive dysfunction in denovo Parkinson’s disease

    K. Baik, S. Lee, M. Park (Seoul, Republic of Korea)

    Objective: To investigate the relationship between cognitive function and vestibulo-ocular reflex (VOR) gain in denovo Parkinson’s disease (PD). Background: Saccades are rapid eye movements necessary…
  • 2024 International Congress

    Dopaminergic alterations in patients with Alzheimer’s disease

    M. Azharuddin, M. Sharma (New Delhi, India)

    Objective: The objective of this study was to conduct a meta-analysis to determine the pooled mean difference (MD) in dopaminergic measures between Alzheimer’s disease and…
  • 2024 International Congress

    Creation and Performance of a Cognitive Summary Score in de novo Parkinson’s Disease: Results from the PPMI Study

    M. Brumm, R. Kurth, M. York, D. Weintraub ()

    Objective: To determine if a cognitive summary score (CSS) is sensitive in detecting early cognitive deficits in de novo Parkinson’s disease (PD). Background: Cognitive impairment…
  • 2024 International Congress

    Critically Evaluating Best Practice Guidelines for Cognitive Impairment in Parkinson’s Disease: A Systematic Review (PDCogniCare)

    D. Pourzinal, D. Bailey, J. Yang, L. Mitchell, N. Pachana, D. Brooks, SA. Keramat, K. Shrubsole, J. Liddle, H. Tinson, S. Naismith, A. Lehn, R. Marsh, N. Dissanayaka (HERSTON, Australia)

    Objective: This systematic review aimed to critically evaluate current recommendations for evaluation, diagnosis and post-diagnostic care of cognitive impairment in Parkinson's disease (PD). Background: Methods…
  • 2024 International Congress

    Prevalence of Cognitive Disorders and Other Features of Parkinson’s Disease in Kyrgyz Republic

    E. Eralieva, M. Moldokulova, K. Dzholboldieva (Osh, Kyrgyzstan)

    Objective: The aim of the study is to determine the clinical and epidemiological features of PD in low-income countries on the example of Kyrgyzstan. Background:…
  • 2024 International Congress

    Developing a Supervised Machine Learning Model for Long-Term Cognitive Status Prediction in Parkinson Disease

    L. Saadatpour, A. Vijayakumari, D. Floden, H. Fernandez, B. Walter (Cleveland, USA)

    Objective: The study aims to develop a supervised machine learning (ML) model to predict long-term cognitive outcome in patients with Parkinson disease (PD). Background: Cognitive…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley